News

The FDA has approved Widaplik, a triple-drug combination, for the treatment of hypertension in adults.
The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...
By Lori Solomon HealthDay ReporterWEDNESDAY, June 11, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
Chandigarh: The Armed Forces Tribunal (AFT) questioned the justification given by the ministry of defence (MoD) for denying ...
High blood pressure is caused by a combination of factors, such as age, dietary habits, and coexisting conditions. Learn ...
The proportion of people unaware they have hypertension increased from 2013 to 2023, with the trend varying based on age and ...
Hypertension, a global health crisis affecting over a billion adults, significantly elevates the risk of stroke, aneurysm, ...
Losing a few kilos can reduce blood pressure. Keeping your waistline healthy also decreases the risk of hypertension. Have at ...
Explore how excessive salt consumption is leading to a hypertension epidemic in India, with alarming statistics and expert ...
And in the end, hypertension’s greatest trick is being felt only in absence—when it’s too late to undo its rise. But ...
George Medicines announced the FDA approval of its triple therapy polypill for initial treatment of adults with ...
Panelists discuss how current therapeutic strengths include 15 approved treatments with different mechanisms of action that ...